18th October 2022
This morning we had a visit from Lars Løkke Rasmussen, the ex Danish Prime Minister, at AI Innovation House where our office is located. In fact, him and his political party Moderaterne want to improve the environment for start-up companies by implementing new investment structures and lower the income tax associated with owning company shares. We like the sound of that.
What a great opportunity to meet entrepreneurs from the Nordic Research Institutions and hear about their innovative projects and journeys from idea to biotech start-up. It will be interesting to further explore potential collaborations and support the next steps toward first-in-human clinical trials.
Thank you to the organizer and the Novo Nordic foundation for an inspiring day.
With kind regards
Clinical Project Delivery Manager
Initially, I created the company so I could be more in control of my workload after the first maternity leave and fulfill my dream of being able to work from anywhere.
The vision from the start was to expand as a consultancy and focus on pharmaceuticals and products, addressing unmet therapeutic needs and supporting the treatment of patients who did not have many options to manage their condition.
For example, one of our first projects was gene therapy for Beta-thalassemiaor support for Paroxysmal nocturnal haemoglobinuria studies. AnRes Clinical has also supported several projects in oncology. Since 2018 our core team and our partners have been deeply involved in 20 clinical trials, clinical investigations, and smaller dedicated assignments as part of AnRes Clinical operations.
With the level of engagement in projects, we genuinely believe AnRes Clinical can offer something unique to our clients.
What makes us different is that we become an integral part of the client´s team, have strong therapeutic expertise, and true passion for clinical and scientific research.
AnRes Clinical vision is to support start-ups and developing companies in drug and product development activities in a structured and open-minded manner.
Thank you to our core team, our partners, and our clients for great 4 years! I am looking forward to many more successful years!
Great thanks and the best takeaway from the AI meets life science, health science and biotech event at Novo Nordisk Foundation.
AnRes clinical wants to express an appreciation to Novo Nordisk Foundation and all co-organizers, for creating such a great event that brought more light to new strategic initiatives in research infrastructure and sustainability. Big thanks to all guest speakers and their hard work that was presented at the scientific sessions.
It was an awesome experience to meet in person amazing and inspirational Veronika Cheplygina from the IT University of Copenhagen. Her presentation about ´´Machine learning in medical imaging: shortcomings and recommendations´´ gave a great perspective on achievements, problems, and possible solutions for imaging.
A lot was achieved with AI, including the detection of pathology in imaging, however, algorithms are still facing numerous problems that need to be addressed. The number1 problem is that even in larger datasets, algorithms can learn shortcuts. Some of the solutions recommended by Dr. Cheplygina are to focus on datasets and most importantly we need to collaborate not compete.
You can learn more from the article.
Thanks to Jonathan P. Gertler, MD for a fantastically delivered talk packed with interesting data on the recent life science investment trends.
It was fascinating to learn that the number of VC deals has almost doubled when comparing 2019 and 2021 in all areas such as biotech, health tech, medical devices, and diagnostics with the most substantial increase in the Health-tech sector.
Jonathan, thanks also for talking about what's considered "hot" investment-wise in each sector. AnRes Clinical gets the take-home message to stay focused on the area one is good at and passionate about in order to make real and meaningful progress. Once again, thank you for this opportunity to gain more insight from you.